BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 19825447)

  • 1. Monoclonal antibody therapy with rituximab for acute lymphoblastic leukemia.
    Thomas DA; O'Brien S; Kantarjian HM
    Hematol Oncol Clin North Am; 2009 Oct; 23(5):949-71, v. PubMed ID: 19825447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia.
    Thomas DA; Faderl S; O'Brien S; Bueso-Ramos C; Cortes J; Garcia-Manero G; Giles FJ; Verstovsek S; Wierda WG; Pierce SA; Shan J; Brandt M; Hagemeister FB; Keating MJ; Cabanillas F; Kantarjian H
    Cancer; 2006 Apr; 106(7):1569-80. PubMed ID: 16502413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies in acute lymphoblastic leukemia.
    Jabbour E; O'Brien S; Ravandi F; Kantarjian H
    Blood; 2015 Jun; 125(26):4010-6. PubMed ID: 25999456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New monoclonal antibodies for the treatment of acute lymphoblastic leukemia.
    Farhadfar N; Litzow MR
    Leuk Res; 2016 Oct; 49():13-21. PubMed ID: 27521873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
    Plosker GL; Figgitt DP
    Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute tumor lysis syndrome induced by rituximab in diffuse large B-cell lymphoma.
    Jabr FI
    Int J Hematol; 2005 Nov; 82(4):312-4. PubMed ID: 16298821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibody-based therapies: a new dawn in the treatment of acute lymphoblastic leukemia.
    Kantarjian H; Thomas D; Wayne AS; O'Brien S
    J Clin Oncol; 2012 Nov; 30(31):3876-83. PubMed ID: 22891271
    [No Abstract]   [Full Text] [Related]  

  • 8. Targeted therapy with monoclonal antibodies in acute lymphoblastic leukemia.
    Hoelzer D
    Curr Opin Oncol; 2013 Nov; 25(6):701-6. PubMed ID: 24097105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab in the management of acute lymphoblastic leukemia.
    Levato L; Molica S
    Expert Opin Biol Ther; 2018 Feb; 18(2):221-226. PubMed ID: 29310477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies in adult acute lymphoblastic leukemia.
    Kantarjian H
    Hematology; 2012 Apr; 17 Suppl 1():S52-4. PubMed ID: 22507779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study of rituximab and ifosfamide, carboplatin, and etoposide chemotherapy in children with recurrent/refractory B-cell (CD20+) non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group.
    Griffin TC; Weitzman S; Weinstein H; Chang M; Cairo M; Hutchison R; Shiramizu B; Wiley J; Woods D; Barnich M; Gross TG;
    Pediatr Blood Cancer; 2009 Feb; 52(2):177-81. PubMed ID: 18816698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress and Innovations in the Management of Adult Acute Lymphoblastic Leukemia.
    Jabbour E; Pui CH; Kantarjian H
    JAMA Oncol; 2018 Oct; 4(10):1413-1420. PubMed ID: 29931220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow infiltration of CD20-negative follicular lymphoma after rituximab therapy: a histological mimicker of hematogones and B-cell acute lymphoblastic leukemia/lymphoma.
    Matsuda I; Hirota S
    Int J Clin Exp Pathol; 2015; 8(8):9737-41. PubMed ID: 26464748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD20 monoclonal antibody (rituximab) for therapy of Epstein-Barr virus lymphoma after hemopoietic stem-cell transplantation.
    Kuehnle I; Huls MH; Liu Z; Semmelmann M; Krance RA; Brenner MK; Rooney CM; Heslop HE
    Blood; 2000 Feb; 95(4):1502-5. PubMed ID: 10666232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of long-term remission of a relapsed childhood B-acute lymphoblastic leukemia with rituximab chimeric anti-CD20 monoclonal antibody and autologous stem cell transplantation.
    Corbacioglu S; Eber S; Gungor T; Hummerjohann J; Niggli F
    J Pediatr Hematol Oncol; 2003 Apr; 25(4):327-9. PubMed ID: 12679650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody therapy for acute lymphoblastic leukemia.
    Portell CA; Advani AS
    Curr Hematol Malig Rep; 2012 Jun; 7(2):153-9. PubMed ID: 22422550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemoimmunotherapy with a modified hyper-CVAD and rituximab regimen improves outcome in de novo Philadelphia chromosome-negative precursor B-lineage acute lymphoblastic leukemia.
    Thomas DA; O'Brien S; Faderl S; Garcia-Manero G; Ferrajoli A; Wierda W; Ravandi F; Verstovsek S; Jorgensen JL; Bueso-Ramos C; Andreeff M; Pierce S; Garris R; Keating MJ; Cortes J; Kantarjian HM
    J Clin Oncol; 2010 Aug; 28(24):3880-9. PubMed ID: 20660823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rituximab as therapy for acute lymphoblastic leukemia.
    Thomas DA
    Clin Adv Hematol Oncol; 2010 Mar; 8(3):168-71. PubMed ID: 20400931
    [No Abstract]   [Full Text] [Related]  

  • 19. Novel targets for treatment of adult acute lymphocytic leukemia.
    Kasner MT
    Curr Hematol Malig Rep; 2010 Oct; 5(4):207-12. PubMed ID: 20680526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel therapeutic strategies in adult acute lymphoblastic leukemia--a focus on emerging monoclonal antibodies.
    Daver N; O'Brien S
    Curr Hematol Malig Rep; 2013 Jun; 8(2):123-31. PubMed ID: 23539383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.